Print

IAVI T001

A Phase 1 Randomized Placebo-controlled Clinical Trial of the Safety, Pharmacokinetics and Antiviral Activity of PGT121 Monoclonal Antibody (mAb) in HIV-uninfected and HIV-infected Adults

Trial Details:

I Ongoing
International AIDS Vaccine Initiative (IAVI) November 01, 2016
PGT121
PGT121 Passive Immunization
USA 63
NCT02960581
https://www.clinicaltrials.gov/ct2/show/NCT02960581